Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review

被引:26
|
作者
Marasine, Nirmal Raj [1 ,2 ]
Sankhi, Sabina [2 ]
Lamichhane, Rajendra [3 ]
Marasini, Nabin Raj [4 ]
Dangi, Nim Bahadur [2 ]
机构
[1] Western Hlth Sci Acad, Pokhara, Kaski, Nepal
[2] Pokhara Univ, Sch Hlth & Allied Sci, Pharmaceut Sci Program, Kaski, Nepal
[3] Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal
[4] La Grande Int Coll, Dept Publ Hlth, Kaski, Nepal
关键词
PRESCRIBING PATTERNS; PRESCRIPTION; PREVALENCE; DISORDERS;
D O I
10.1155/2021/6699028
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction. Depression is a major global health problem with a relatively high lifetime prevalence and significant disability. Antidepressants are the most effective medications used for the treatment of depression. Hence, this study is aimed at summarizing the studies on antidepressant use among patients diagnosed with depression. Method. PubMed, Embase, Web of Science, Scopus, and Google Scholar were searched for literature (2000-2019) using keywords such as depression, drug utilization, antidepressants, prescription, serotonin reuptake inhibitor, serotonin and norepinephrine reuptake inhibitor, tricyclic antidepressants, and atypical antidepressants. Results. Antidepressant users were mostly females, married people, housewives, lower-income people, employees, and highly educated people, as they were found to be more prone to develop depression than their counterparts. Selective serotonin reuptake inhibitors (SSRIs), such as sertraline, were most commonly prescribed among depressive patients. Conclusion. Our study suggested that out of five major antidepressant drugs available for the treatment of depression, selective serotonin reuptake inhibitors are preferred over others because of their better side effects and tolerability profile.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Symptoms and Experience of Depression Among Chinese Communities in the West: A Scoping Review
    Ahmad, Farah
    Maule, Catherine
    Wang, Jamie
    Fung, Wai Lun Alan
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2018, 26 (06) : 340 - 351
  • [42] Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review
    Brown, Lisa C.
    Bobo, William V.
    Gall, Cory A.
    Mueller, Daniel J.
    Bousman, Chad A.
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (07):
  • [43] Screening for depression and anxiety among patients with acute coronary syndrome in acute care settings: a scoping review
    Marin, Tania S.
    Walsh, Sandra
    May, Nikki
    Jones, Martin
    Gray, Richard
    Muir-Cochrane, Eimear
    Clark, Robyn A.
    [J]. JBI EVIDENCE SYNTHESIS, 2020, 18 (09) : 1932 - 1969
  • [44] Adjunctive use of Amisulpride in elderly patients with psychotic depression treated with antidepressants
    Politis, A.
    Theleritis, C.
    Psarros, C.
    Soldatos, Cr
    Papadimitriou, Gn
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 345 - 346
  • [45] Effects of antidepressants on BDNF levels in patients with major depression: a systematic review
    Viceconte, D.
    Sepede, G.
    Lorusso, M.
    Spano, C.
    Baroni, G.
    Di Caprio, L.
    Mancini, V.
    Montemitro, C.
    Di Giannantonio, M.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S199 - S200
  • [46] Predictors of hypomanic and/or manic switch among patients initially diagnosed with unipolar major depression during acute-phase antidepressants treatment
    Akechi, Tatsuo
    Kato, Tadashi
    Watanabe, Norio
    Tanaka, Shiro
    Furukawa, Toshi A.
    Furukawa, Toshi A.
    Akechi, Tatsuo
    Shimodera, Shinji
    Yamada, Mitsuhiko
    Inagaki, Masatoshi
    Watanabe, Norio
    Yonemoto, Naohiro
    Miki, Kazuhira
    Ogawa, Yusuke
    Takeshima, Nozomi
    Tajika, Aran
    Higuchi, Teruhiko
    Hirayasu, Yoshio
    Kada, Akiko
    Koyama, Tsukasa
    Kusumi, Ichiro
    Inoue, Takeshi
    Kako, Yuki
    Kasai, Kiyoto
    Suga, Motomu
    Mizuno, Masafumi
    Tsujino, Naohisa
    Akechi, Tatsuo
    Kondo, Masaki
    Yamawaki, Shigeto
    Okamoto, Yasumasa
    Inoue, Shinpei
    Morinobu, Shigeru
    Shimodera, Shinji
    Uchimura, Naohisa
    Yasumoto, Shingo
    Mori, Keiichiro
    Ikeda, Manabu
    Fujise, Noboru
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 73 (02) : 90 - 91
  • [47] The methods of improving cultural sensitivity of depression scales for use among global indigenous populations: a systematic scoping review
    Gomez Cardona, Liliana
    Yang, Michelle
    Seon, Quinta
    Karia, Maharshee
    Velupillai, Gajanan
    Noel, Valerie
    Linnaranta, Outi
    Linnaranta, Outi
    Farnbach, Sara
    Fisher, Jane
    Chibanda, Dixon
    Linnaranta, Outi
    Fisher, Jane
    Chibanda, Dixon
    Linnaranta, Outi
    Fisher, Jane
    Chibanda, Dixon
    [J]. CAMBRIDGE PRISMS-GLOBAL MENTAL HEALTH, 2023, 10
  • [48] Antidepressants for treatment of depression in palliative patients. A systematic literature review
    Ujeyl, M.
    Mueller-Oerlinghausen, B.
    [J]. SCHMERZ, 2012, 26 (05): : 523 - 536
  • [49] Wealth and depression: A scoping review
    Ettman, Catherine K.
    Adam, Gaelen P.
    Clark, Melissa A.
    Wilson, Ira B.
    Vivier, Patrick M.
    Galea, Sandro
    [J]. BRAIN AND BEHAVIOR, 2022, 12 (03):
  • [50] RETROSPECTIVE ANALYSIS TO DETERMINE THE INCREASED RISK OF DEVELOPING OSTEOPOROSIS IN PATIENTS DIAGNOSED WITH DEPRESSION AND/OR PRESCRIBED ANTIDEPRESSANTS
    Kandasamy, T.
    Raupp, M.
    Ashrafzadeh, A.
    Krishnan, B.
    Gregg, J.
    Zhang, H.
    Balusu, J. C.
    Barcella, W.
    Lorenzo, R.
    Dee, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S214 - S214